| Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas MS Anglesio, S Kommoss, MC Tolcher, B Clarke, L Galletta, H Porter, ... The Journal of pathology 229 (1), 111-120, 2013 | 237 | 2013 |
| miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma HWZ Khella, M Bakhet, G Allo, MAS Jewett, AH Girgis, A Latif, H Girgis, ... Carcinogenesis 34 (10), 2231-2239, 2013 | 191 | 2013 |
| ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas G Allo, MQ Bernardini, RC Wu, IM Shih, S Kalloger, A Pollett, CB Gilks, ... Modern Pathology 27 (2), 255-261, 2014 | 131 | 2014 |
| Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma EL Stewart, C Mascaux, NA Pham, S Sakashita, J Sykes, L Kim, ... Journal of Clinical Oncology 33 (22), 2472-2480, 2015 | 107 | 2015 |
| Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials … AV Tinker, S Ellard, S Welch, F Moens, G Allo, MS Tsao, J Squire, D Tu, ... Gynecologic oncology 130 (2), 269-274, 2013 | 107 | 2013 |
| Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer D Tsoref, S Welch, S Lau, J Biagi, K Tonkin, LA Martin, S Ellard, ... Gynecologic oncology 135 (2), 184-189, 2014 | 96 | 2014 |
| Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors D Wang, NA Pham, J Tong, S Sakashita, G Allo, L Kim, N Yanagawa, ... International journal of cancer 140 (3), 662-673, 2017 | 82 | 2017 |
| Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors FI Lu, CB Gilks, AM Mulligan, P Ryan, G Allo, K Sy, PA Shaw, A Pollett, ... International journal of gynecological pathology 31 (6), 524-531, 2012 | 75 | 2012 |
| Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 … D Rayson, S Lupichuk, K Potvin, S Dent, T Shenkier, S Dhesy-Thind, ... Breast cancer research and treatment 157, 109-116, 2016 | 52 | 2016 |
| Patient-derived xenograft establishment from human malignant pleural mesothelioma L Wu, G Allo, T John, M Li, T Tagawa, I Opitz, M Anraku, Z Yun, M Pintilie, ... Clinical Cancer Research 23 (4), 1060-1067, 2017 | 51 | 2017 |
| Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers S Campbell, I Poon, D Markel, D Vena, K Higgins, D Enepekides, ... International Journal of Radiation Oncology* Biology* Physics 82 (2), 574-581, 2012 | 51 | 2012 |
| HPV-independent vulvar squamous cell carcinoma is associated with significantly worse prognosis compared with HPV-associated tumors G Allo, ML Yap, J Cuartero, M Milosevic, S Ferguson, H Mackay, ... International Journal of Gynecological Pathology 39 (4), 391-399, 2020 | 50 | 2020 |
| Noninvasive in vivo structural and vascular imaging of human oral tissues with spectral domain optical coherence tomography B Davoudi, A Lindenmaier, BA Standish, G Allo, K Bizheva, A Vitkin Biomedical optics express 3 (5), 826-839, 2012 | 49 | 2012 |
| Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non–Small Cell Lung Cancer Xenograft Models J Hai, S Sakashita, G Allo, O Ludkovski, C Ng, FA Shepherd, MS Tsao Journal of Thoracic Oncology 10 (8), 1172-1180, 2015 | 40 | 2015 |
| Review of findings in prophylactic gynaecological specimens in L ynch syndrome with literature review and recommendations for grossing MR Downes, G Allo, WG McCluggage, K Sy, SE Ferguson, M Aronson, ... Histopathology 65 (2), 228-239, 2014 | 36 | 2014 |
| PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy BKY Bitanihirwe, M Meerang, M Friess, A Soltermann, L Frischknecht, ... Journal of thoracic oncology 9 (2), 239-247, 2014 | 35 | 2014 |
| Use of mismatch repair immunohistochemistry and microsatellite instability testing: exploring Canadian practices SE Kalloger, G Allo, AM Mulligan, A Pollett, M Aronson, S Gallinger, ... The American journal of surgical pathology 36 (4), 560-569, 2012 | 33 | 2012 |
| Epidermal growth factor receptor mutation‐specific immunohistochemical antibodies in lung adenocarcinoma G Allo, B Bandarchi, N Yanagawa, A Wang, W Shih, J Xu, M Dalby, ... Histopathology 64 (6), 826-839, 2014 | 32 | 2014 |
| Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer I Mert, J Chhina, G Allo, J Dai, S Seward, MS Carey, M Llaurado, S Giri, ... Gynecologic oncology 146 (2), 319-326, 2017 | 31 | 2017 |
| Prognostic significance of human papilloma virus and p16 expression in patients with vulvar squamous cell carcinoma who received radiotherapy ML Yap, G Allo, J Cuartero, M Pintilie, S Kamel-Reid, J Murphy, H Mackay, ... Clinical Oncology 30 (4), 254-261, 2018 | 20 | 2018 |
